Vivos Therapeutics, Inc. Stock-Based Compensation
Vivos Therapeutics, Inc. (VVOS) reported Stock-Based Compensation of $201.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- Vivos Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $50.00K, a 79.34% decline year-over-year.
- Vivos Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $151.00K, a 52.37% decline year-over-year.
- Vivos Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $47.00K, a 17.54% decline year-over-year.
- Vivos Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $55.00K, a 61.27% decline year-over-year.
- Vivos Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $661.00K, a 13.25% decline from fiscal 2024.
- Vivos Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $762.00K, a 31.10% decline from fiscal 2023.
- Vivos Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $1.11M, a 53.84% decline from fiscal 2022.
- Vivos Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $2.40M, a 9.86% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $201.00K 10-Q · filed 2026-08-14 | $248.00K derived: sum of 3 quarters · filed 2026-08-14 | $303.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $151.00K 10-Q · filed 2026-05-20 | $198.00K derived: sum of 2 quarters · filed 2026-05-20 | $253.00K derived: sum of 3 quarters · filed 2026-05-20 | $495.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $102.00K derived: sum of 2 quarters · filed 2026-04-15 | $344.00K derived: sum of 3 quarters · filed 2026-08-14 | $661.00K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $297.00K derived: sum of 2 quarters · filed 2026-08-14 | $614.00K 10-Q · filed 2025-11-19 | $671.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $242.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $559.00K 10-Q · filed 2026-08-14 | $616.00K derived: sum of 3 quarters · filed 2026-08-14 | $758.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $317.00K 10-Q · filed 2026-05-20 | $374.00K derived: sum of 2 quarters · filed 2026-05-20 | $516.00K derived: sum of 3 quarters · filed 2026-05-20 | $786.00K derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $199.00K derived: sum of 2 quarters · filed 2026-04-15 | $469.00K derived: sum of 3 quarters · filed 2026-04-15 | $762.00K 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | $142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $412.00K derived: sum of 2 quarters · filed 2025-11-19 | $705.00K 10-Q · filed 2025-11-19 | $857.00K derived: sum of 4 quarters · filed 2025-11-19 | ||||
| 2024-06-30 | $270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $563.00K 10-Q · filed 2025-08-19 | $715.00K derived: sum of 3 quarters · filed 2025-08-19 | $904.00K derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | $293.00K 10-Q · filed 2025-05-15 | $445.00K derived: sum of 2 quarters · filed 2025-05-15 | $634.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.09M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $341.00K derived: sum of 2 quarters · filed 2025-03-31 | $800.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.11M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $189.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $648.00K derived: sum of 2 quarters · filed 2024-11-14 | $954.00K 10-Q · filed 2024-11-14 | $1.73M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $459.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $765.00K 10-Q · filed 2024-08-14 | $1.54M derived: sum of 3 quarters · filed 2024-08-14 | $1.89M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $306.00K 10-Q · filed 2024-05-14 | $1.08M derived: sum of 2 quarters · filed 2024-07-30 | $1.43M derived: sum of 3 quarters · filed 2024-07-30 | $2.09M derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2022-12-31 | $775.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-07-30 | $1.13M derived: sum of 2 quarters · filed 2024-07-30 | $1.79M derived: sum of 3 quarters · filed 2024-07-30 | $2.40M 10-K/A · filed 2024-07-30 | ||||
| 2022-09-30 | $350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.01M derived: sum of 2 quarters · filed 2023-11-14 | $1.62M 10-Q · filed 2023-11-14 | $2.08M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $662.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | $1.27M 10-Q · filed 2023-08-16 | $1.73M derived: sum of 3 quarters · filed 2023-08-16 | $2.85M derived: sum of 4 quarters · filed 2023-08-16 | ||||
| 2022-03-31 | $609.00K 10-Q · filed 2023-06-08 | $1.07M derived: sum of 2 quarters · filed 2023-06-08 | $2.19M derived: sum of 3 quarters · filed 2023-06-08 | $2.83M derived: sum of 4 quarters · filed 2023-06-08 | ||||
| 2021-12-31 | $463.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.58M derived: sum of 2 quarters · filed 2023-03-30 | $2.22M derived: sum of 3 quarters · filed 2023-03-30 | $2.66M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | $1.76M derived: sum of 2 quarters · filed 2022-12-20 | $2.19M 10-Q · filed 2022-12-20 | $2.19M 10-Q · filed 2021-11-15 | $3.02M derived: sum of 4 quarters · filed 2022-12-20 | |||
| 2021-06-30 | $648.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-12-20 | $1.08M 10-Q · filed 2022-12-20 | $1.08M 10-Q · filed 2021-08-12 | $1.91M derived: sum of 3 quarters · filed 2022-12-20 | $2.34M derived: sum of 4 quarters · filed 2022-12-20 | |||
| 2021-03-31 | $434.00K 10-Q/A · filed 2022-11-25 | $434.29K 10-Q · filed 2021-05-17 | $1.26M derived: sum of 2 quarters · filed 2022-11-25 | $1.69M derived: sum of 3 quarters · filed 2022-11-25 | $2.25M derived: sum of 4 quarters · filed 2022-11-25 | |||
| 2020-12-31 | $826.07K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.25M derived: sum of 2 quarters · filed 2022-03-31 | $1.82M derived: sum of 3 quarters · filed 2022-03-31 | $2.17M 10-K · filed 2022-03-31 | $2.17M 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $428.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $994.04K derived: sum of 2 quarters · filed 2021-11-15 | $1.35M 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | $565.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $917.27K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $351.89K 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | $1.99M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |